Market Cap
17220182016.00
Manhattan Associates, Inc.
Exchange: nyse
The ticker symbol MANH represents MannKind Corporation, a biopharmaceutical company listed on the New York Stock Exchange (NYSE). MannKind is primarily known for developing and commercializing inhaled therapeutic products, with its flagship product being Afrezza, a rapid-acting inhalable insulin used to improve glycemic control in adults with diabetes. The company continues to focus on advancing its technologies and expanding the reach of its products to benefit patients around the world.
-1.105588930824
0.259510576487
27.85%
3.75